Cancers, Vol. 14, Pages 1506: Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
Cancers, Vol. 14, Pages 1506: Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
Cancers doi: 10.3390/cancers14061506
Authors:
Puja Dey
Kentaro Nakayama
Sultana Razia
Masako Ishikawa
Tomoka Ishibashi
Hitomi Yamashita
Kosuke Kanno
Seiya Sato
Tohru Kiyono
Satoru Kyo
Despite the knowledge about numerous genetic mutations essential for the progression of low-grade serous ovarian carcinoma (LGSOC), the specific combination of mutations required remains unclear. Here, we aimed to recognize the oncogenic mutations responsible for the stepwise development of LGSOC using immortalized HOVs-cyst-1 cells, developed from ovarian serous cystadenoma cells, and immortalized via cyclin D1, CDK4R24C, and hTERT gene transfection. Furthermore, oncogenic mutations, KRAS and PIK3CA, were individually and simultaneously introduced in immortalized HOV-cyst-1 cells. Cell functions were subsequently analyzed via in vitro assays. KRAS or PIK3CA double mutant HOV-cyst-1 cells exhibited higher cell proliferation and migration capacity than the wild-type cells, or those with either a KRAS or a PIK3CA mutation, indicating that these mutations play a causative role in LGSOC tumorigenesis. Moreover, KRAS and PIK3CA double mutants gained tumorigenic potential in nude mice, whereas the cells with a single mutant exhibited no signs of tumorigenicity. Furthermore, the transformation of HOV-cyst-1 cells with KRAS and PIK3CA mutants resulted in ...
Source: Cancers - Category: Cancer & Oncology Authors: Puja Dey Kentaro Nakayama Sultana Razia Masako Ishikawa Tomoka Ishibashi Hitomi Yamashita Kosuke Kanno Seiya Sato Tohru Kiyono Satoru Kyo Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cystadenoma | Genetics | Ovarian Cancer | Ovaries | Serous Carcinoma